Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 394,653 |
|
|||||
| News | - | ||||||
| Day High | 38.00 | Low High |
|||||
| Day Low | 36.96 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celldex Therapeutics Inc | CLDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.75 | -1.99% | 37.02 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 37.87 | 36.96 | 38.00 | 37.02 | 37.77 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,455 | 394,653 | $ 37.32 | $ 14,729,982 | - | 22.11 - 53.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:20:00 | 30 | $ 37.02 | USD |
Celldex Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.07B | 55.90M | - | 6.88M | -141.43M | -2.53 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Celldex Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLDX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 38.87 | 40.45 | 36.78 | 38.71 | 622,509 | -1.85 | -4.76% |
| 1 Month | 41.33 | 42.38 | 36.78 | 39.89 | 623,212 | -4.31 | -10.43% |
| 3 Months | 36.02 | 53.18 | 34.65 | 43.32 | 961,337 | 1.00 | 2.78% |
| 6 Months | 24.44 | 53.18 | 22.11 | 37.81 | 885,402 | 12.58 | 51.47% |
| 1 Year | 36.51 | 53.18 | 22.11 | 35.64 | 673,891 | 0.51 | 1.40% |
| 3 Years | 27.99 | 57.20 | 19.85 | 35.72 | 626,612 | 9.03 | 32.26% |
| 5 Years | 4.03 | 57.20 | 1.50 | 24.92 | 662,179 | 32.99 | 818.61% |
Celldex Therapeutics Description
| Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. |
